Intrinsic Value of S&P & Nasdaq Contact Us

Syndax Pharmaceuticals, Inc. SNDX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$39.33
+61%

Syndax Pharmaceuticals, Inc. (SNDX) has 12 identified peers for comparison in the Healthcare sector. Peers include AVTE, CGEM, COGT, CYTK, DICE, DYN and others.

SNDX has a market capitalization of $2.15B, compared to an average peer market cap of $3.24B.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message